Bangun Kosambi Sukses Tbk. vs Merck Tbk. — how do they compare? Bangun Kosambi Sukses Tbk. trades at Rp3,530 (market cap 19.84T, 690K 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 26.9K 24h volume). The key difference: Bangun Kosambi Sukses Tbk. is far larger — about 11.7× Merck Tbk.'s market cap, and Bangun Kosambi Sukses Tbk. is more actively traded (690K versus 26.9K). Which is the better fit depends on your goals.
| CBDK | MERK | |
|---|---|---|
Market Cap | 19.84T | 1.7T |
Volume | 690K | 26.9K |
Lot | 6.9K | 269 |
Turnover | 2.42B | 103.24M |
Average Price | 3,510.08 | 3,837.73 |
Value | 2.42B | 103.24M |
Indicative Equilibrium Price | 3,550 | 3,850 |
Indicative Equilibrium Volume | 7 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bangun Kosambi Sukses Tbk (the Company) was established based on Notarial Deed No. 01 of Djedjem Widjaja, S.H., M.H., dated 3 April 2000. The Company commenced its commercial operations in 2020. The Company is controlled by its immediate parent company, PT Pantai Indah Kapuk Dua Tbk, domiciled in Jakarta and its ultimate parent companies are PT Agung Sedayu and PT Tunas Mekar Jaya, domiciled in Jakarta.
Read more on CBDK →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →